Results 51 to 60 of about 197,741 (365)

Protection against Covid-19 by BNT162b2 Booster across Age Groups

open access: yesNew England Journal of Medicine, 2021
Background After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to persons 60 years of age or older, the booster campaign in Israel was gradually expanded to persons in ...
Y. Bar-On   +8 more
semanticscholar   +1 more source

A randomised controlled trial and cost-effectiveness evaluation of 'booster' interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods [PDF]

open access: yes, 2014
Background: More evidence is needed on the potential role of 'booster' interventions in the maintenance of increases in physical activity levels after a brief intervention in relatively sedentary populations.
Daniel Hind   +54 more
core   +1 more source

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

open access: yesMMWR. Morbidity and mortality weekly report, 2022
Four COVID-19 vaccines are currently approved for primary series vaccination in the United States under a Biologics License Application or authorized under an emergency use authorization (EUA) by the Food and Drug Administration (FDA), and recommended ...
Hannah G. Rosenblum   +17 more
semanticscholar   +1 more source

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant

open access: yesMedComm, 2022
The SARS‐CoV‐2 Omicron BA.1 variant of concern contains more than 30 mutations in the spike protein, with half of these mutations localized in the receptor‐binding domain (RBD).
Zhongcheng Zhou   +17 more
doaj   +1 more source

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022

open access: yesMMWR. Morbidity and mortality weekly report, 2023
COVID-19 vaccine booster doses are safe and maintain protection after receipt of a primary vaccination series and reduce the risk for serious COVID-19-related outcomes, including emergency department visits, hospitalization, and death (1,2).
P. Lu   +14 more
semanticscholar   +1 more source

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

open access: yesVaccines, 2022
Objective: Vaccination hesitance for the COVID-19 booster dosage among hemodialysis patients is an important barrier in reducing morbidity and mortality linked to COVID-19 infection. Hence, this study aimed to explore the predictors of the third (booster)
Sami Alobaidi   +6 more
doaj   +1 more source

JURECA: Data Centric and Booster Modules implementing the Modular Supercomputing Architecture at Jülich Supercomputing Centre

open access: yesJournal of large-scale research facilities JLSRF, 2021
JURECA is a Pre-Exascale Modular Supercomputer operated by Jülich Supercomputing Centre at Forschungszentrum Jülich. The system combines a flexible Data Centric (DC) module, based on the Atos BullSequana XH2000 with a selection of best-of-its-kind ...
Philipp Thörnig
semanticscholar   +1 more source

Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans

open access: yesImmunity
SUMMARY Immune imprinting describes how the first exposure to a virus shapes immunological outcomes of subsequent exposures to antigenically related strains.
M. A. Tortorici   +9 more
semanticscholar   +1 more source

Insights from Team Clinic: A Person-Centered Virtual Peer Group Care Model Adapted for Marginalized and Historically Excluded Youth with Type 1 Diabetes (T1D)

open access: yesChildren
Background: Despite advancements in T1D care regimens, racially and ethnically diverse youth with low income continue to experience worse health outcomes, more psychosocial challenges, and higher barriers to care.
Jaquelin Flores Garcia   +8 more
doaj   +1 more source

TRUST AS A BOOSTER

open access: yesJournal of Business Economics and Management, 2017
In his book Trust. The Evolutionary Game of Mind and Society, social psychologist Toshio Yamagishi (2011) states that trust can be viewed as a “booster rocket” that provides the necessary push for the take-off from the secure ground of committed relations. This article formalizes this idea with the help of a simple game theoretic model.
openaire   +4 more sources

Home - About - Disclaimer - Privacy